In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) and the Paul Ehrlich Institute are responsible for approving clinical trials. In addition, a favourable opinion from an independent ethics committee is usually required to protect the rights, safety and well-being of trial participants.